Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 12, 2019updated 06 Dec 2021 11:35am

Smith & Nephew reports positive data for Novostitch

Medical technology firm Smith & Nephew has announced positive, six-month data from the STITCHtrial of its Novostitch Meniscal Repair System.

Medical technology firm Smith & Nephew has announced positive six-month data from the STITCH trial of its Novostitch Meniscal Repair System.

Novostitch is intended for complex meniscal tear patterns that are not adequately addressed by other repair systems.

The prospective study assessed the effectiveness of the device in repairing common meniscal tears known as horizontal cleavage tears (HCTs) in 30 patients at eight sites across the US.

It assessed meniscal healing at second look needle arthroscopy, freedom from re-operation and improvements in knee pain and function measured as patient reported outcomes (PROs).

At six months, complete meniscal healing was observed upon second look arthroscopy, along with a 0% re-operation rate and significant improvements in all PROs.

STITCH study co-author Dr David Flanigan said: “These initial STITCH results demonstrating successful HCT repair are very promising. This is exciting to see, as many patients are affected by these types of meniscal tears, which have previously been considered irreparable.”

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Previously, HCTs were treated by partial resection via meniscectomy. However, this procedure is associated with risk of adverse knee joint changes, which could eventually lead to osteoarthritis or total knee replacement.

Novostitch is designed to allow surgeons to make circumferential compression stitches in locations that were not previously possible. This is said to expand the meniscal repair option for several patients.

The device complements Smith & Nephew’s Fast-Fix 360 Meniscal Repair System, which is meant for vertical tears.

Smith & Nephew Global Sports Medicine and ENT president Brad Cannon said: “There are currently more than 1.2 million meniscal tears treated surgically in the US each year with only 15-20% of the cases receiving a meniscal repair, rather than removal.

“With products like Novostitch Pro and Fast-Fix 360 we see the opportunity to double this proportion in the medium term.”

Data from the STITCH trial was presented at the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) held in Cancun, Mexico in May.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU